Relmada Therapeutics Inc (NAS:RLMD)
$ 3.64 0.11 (3.12%) Market Cap: 109.83 Mil Enterprise Value: 10.34 Mil PE Ratio: 0 PB Ratio: 1.28 GF Score: 31/100

Relmada Therapeutics Inc (RLMD) Stock Estimates Data

Relmada Therapeutics Inc (RLMD) 12 Month Price Targets

Relmada Therapeutics Inc (RLMD) Analyst Rating